Company intelligence / Profile preview

Medicair

Pallini, Attica, Greecemedicairgroup.com ↗
Ownership
Private
Development stage
Other
01

Overview

Medicair is an established European pharmaceutical company specializing in the manufacture and distribution of generic medicines across multiple dosage forms. The company is one of the few in Europe with specialized expertise in manufacturing MDI inhalers, nasal sprays, and pharmaceutical aerosols. Its products are commercialized internationally across Europe and other global markets.

Therapeutic areas
EndocrinologyImmunologyRheumatologyGastroenterologyCardiovascularNeurologyInfectious Diseases
Modalities
Small moleculeDevice
Industry
Biotech

Beyond the preview

Go deeper on Medicair.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

  • Partners
  • Deal terms
  • Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

  • Funding rounds
  • Investors
  • Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

  • Peer companies
  • Targets
  • Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

  • Platforms
  • Patents
  • Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

  • Company news
  • Sources
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Medicair.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call